Overview

This trial is active, not recruiting.

Condition obstructive sleep apnea
Treatment obstructive sleep apnea
Sponsor Karolinska University Hospital
Collaborator Umeå University
Start date November 2014
End date February 2017
Trial size 449 participants
Trial identifier NCT02293421, OSA STOP-BANG

Summary

Although obstructive sleep apnea (OSA) is common, most of the patients are undiagnosed. OSA is associated with a large number of co-morbidities, and thus, it is of great importance to identify the patients and start treatment in order to reduce the risks for complications. Current screening tools are quite unspecific and the golden standard methodology for diagnosis, polysomnography, is expensive and time consuming, thus not suitable for screening. In perioperative medicine the STOP BANG screening questionnaire is currently the recomended screening tool, however this questionnaire has only been evaluated in a sleep clinic in a very limited numbers of patients.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Intervention model single group assignment
Masking open label
Primary purpose diagnostic
Arm
(Other)
STOP BANG screening questionnaire and a snore question
obstructive sleep apnea

Primary Outcomes

Measure
STOP BANG
time frame: At diagnosis, one time
Snore question
time frame: At diagnosis, one time
Polygraphy
time frame: At diganosis, one time

Secondary Outcomes

Measure
Pulseoximetry
time frame: At dignosis, one time

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - More than 18 years old - First or part of the first visit to a sleep clinic - Planned or just conducted polysomography Exclusion Criteria: - Not able to understand the information and sign informed consent

Additional Information

Official title Evaluation of the STOP-BANG Screening Questionnaire in a Sleep Clinic
Principal investigator Malin Jonsson Fagerlund, MD, PhD
Trial information was received from ClinicalTrials.gov and was last updated in October 2016.
Information provided to ClinicalTrials.gov by Karolinska University Hospital.